PS Ratio: 56.81

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 56.81 is 55% above its estimated 4-year average of 36.74, near the low end of its estimated 4-year range (2.80–264.14).

As of 2026-10-06T19:13:43.523Z. 76.69% above its estimated 12-month average of 32.15.

STOK PS Ratio Metrics

P/S vs. estimated history

At 56.81, P/S is above its estimated 4-year median — higher than 71% of readings in its estimated 4-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Stoke Therapeutics, Inc. (STOK)?

The P/S ratio for STOK stock is 56.81.

Is Stoke Therapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 56.81 is 55% above its estimated 4-year average of 36.74, near the low end of its estimated 4-year range (2.80–264.14).

What is the estimated TTM average P/S ratio for Stoke Therapeutics, Inc. (STOK)?

The estimated TTM average P/S ratio for STOK stock is 32.15.

What is the estimated 3Y average P/S ratio for Stoke Therapeutics, Inc. (STOK)?

The estimated 3Y average P/S ratio for STOK stock is 33.78.

Showing the most recent 260 of 1,104 data points. The chart above shows the full history.

Related Metrics